Citation: K. Shimizu et al., SYSTEMIC ADMINISTRATION OF INTERLEUKIN-2 ENHANCES THE THERAPEUTIC EFFICACY OF DENDRITIC CELL-BASED TUMOR VACCINES, Journal of leukocyte biology, 1998, pp. 20-20
Authors:
NIELSEN OH
KIRMAN I
JOHNSON K
GIEDLIN M
CIARDELLI T
Citation: Oh. Nielsen et al., THE CIRCULATING COMMON GAMMA-CHAIN (CD132) IN INFLAMMATORY BOWEL-DISEASE, The American journal of gastroenterology, 93(3), 1998, pp. 323-328
Authors:
FREEDMAN RS
GIBBONS JA
GIEDLIN M
KUDELKA AP
KAVANAGH JJ
EDWARDS CL
CARRASCO CH
NASH MA
PLATSOUCAS CD
Citation: Rs. Freedman et al., IMMUNOPHARMACOLOGY AND CYTOKINE PRODUCTION OF A LOW-DOSE SCHEDULE OF INTRAPERITONEALLY ADMINISTERED HUMAN RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN-CARCINOMA, Journal of immunotherapy with emphasis on tumor immunology, 19(6), 1996, pp. 443-451
Citation: Rd. Dix et al., CYTOKINE IMMUNOTHERAPY FOR CYTOMEGALOVIRUS RETINITIS IN MICE WITH MAIDS, Investigative ophthalmology & visual science, 37(3), 1996, pp. 3067-3067
Citation: Rd. Dix et al., EVALUATION OF PEG-MODIFIED HUMAN RECOMBINANT INTERLEUKIN-2 AS IMMUNOTHERAPY FOR CYTOMEGALOVIRUS RETINITIS IN MICE WITH MAIDS, Investigative ophthalmology & visual science, 36(4), 1995, pp. 324-324